PDS Biotechnology Corporation
Hedge Funds Holdings
Last updated:
PDS Biotechnology Corporation‘s stocks are currently a part of 39 hedge funds’ portfolios, which represents 8.04% of the total amount of its stocks outstanding. This makes up a total of 2.30M shares of PDS Biotechnology Corporation. Compared to the previous quarter, the number fell by -66.22% or -4.51M shares fewer. As for the holding position changes, 33.33% (13) of current hedge fund investors increased the number of shares held, 25.64% (10) of current holders sold a part of the shares held, and 15.38% (6) closed the holdings completely. 7 hedge funds are new holders of PDS Biotechnology Corporation stock in Q1 2023, it is 17.95% of total holders.
Hedge funds holding PDS Biotechnology (Q1 2019 – Q1 2023)
Q1 2019 | 14 |
---|---|
Q2 2019 | 17 |
Q3 2019 | 16 |
Q4 2019 | 16 |
Q1 2020 | 21 |
Q2 2020 | 19 |
Q3 2020 | 25 |
Q4 2020 | 25 |
Q1 2021 | 29 |
Q2 2021 | 43 |
Q3 2021 | 59 |
Q4 2021 | 65 |
Q1 2022 | 53 |
Q2 2022 | 52 |
Q3 2022 | 45 |
Q4 2022 | 63 |
Q1 2023 | 39 |
Hedge funds changes in PDS Biotechnology positions (Q1 2019 – Q1 2023)
Q1 2019 | 14 | 0 | 0 | 0 | 0 |
---|---|---|---|---|---|
Q2 2019 | 7 | 3 | 4 | 4 | -1 |
Q3 2019 | 3 | 4 | 0 | 4 | 5 |
Q4 2019 | 2 | 2 | 6 | 2 | 4 |
Q1 2020 | 8 | 3 | 3 | 3 | 4 |
Q2 2020 | 6 | 5 | 1 | 8 | -1 |
Q3 2020 | 10 | 6 | 0 | 4 | 5 |
Q4 2020 | 6 | 7 | 2 | 6 | 4 |
Q1 2021 | 12 | 7 | 6 | 8 | -4 |
Q2 2021 | 25 | 8 | 4 | 11 | -5 |
Q3 2021 | 21 | 19 | 12 | 5 | 2 |
Q4 2021 | 19 | 26 | 11 | 12 | -3 |
Q1 2022 | 7 | 20 | 13 | 19 | -6 |
Q2 2022 | 11 | 14 | 13 | 12 | 2 |
Q3 2022 | 9 | 13 | 10 | 15 | -2 |
Q4 2022 | 27 | 17 | 9 | 7 | 3 |
Q1 2023 | 7 | 13 | 10 | 6 | 3 |
Hedge funds changes in PDS Biotechnology stock options (Q1 2019 – Q1 2023)
Q1 2019 | 102,000 | 0 |
---|---|---|
Q2 2019 | 0 | 0 |
Q3 2019 | 0 | 0 |
Q4 2019 | 0 | 0 |
Q1 2020 | 0 | 0 |
Q2 2020 | 0 | 0 |
Q3 2020 | 0 | 0 |
Q4 2020 | 0 | 0 |
Q1 2021 | 0 | 0 |
Q2 2021 | 2,746,000 | 3,898,000 |
Q3 2021 | 4,558,000 | 3,027,000 |
Q4 2021 | 1,534,000 | 1,012,000 |
Q1 2022 | 2,938,000 | 710,000 |
Q2 2022 | 2,643,000 | 978,000 |
Q3 2022 | 2,050,000 | 241,000 |
Q4 2022 | 12,051,600 | 2,512,800 |
Q1 2023 | 40,738,000 | 12,330,000 |